Fact CheckerSign in

NCT07133347CompletedPhase 1

Creating an Engaging BCI/FES Therapy for Children With Perinatal Stroke Using Social Media

Source: ClinicalTrials.gov · Last updated 21 Aug 2025

Brief summary (registry, in English)

The goal of this trial is to evaluate the feasibility of a brain-computer interface controlled functional electrical stimulation (BCI-FES) social media integrated system for children with hemiparetic cerebral palsy . The main questions it aims to answer is: (1) Is the social media BCI-FES system a feasible therapeutic intervention?

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
12 (actual)
First submitted
15 Jul 2025
Start date
25 Nov 2024
Primary completion date
20 Apr 2025
Lead sponsor
University of Calgary
Diseases
Stroke
NCT number
NCT07133347

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 12
  • From 25 Nov 2024 to the primary completion date, 20 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Exclusion criteria include severe intellectual disability, unstable epilepsy, and orthopaedic surgery in the upper limb or botulinum toxin injection in the previous 6 months.

Who the study is looking for

  • -The investigators recruited participants 10-25 years, with perinatal stroke and disabling hemiparetic cerebral palsy.

Age in the registry: 10 years to 25 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Alberta Children's Hospital
Coordinator of this site? Confirm its status
CalgaryCanadaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.